We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Misonix Inc. (MSON)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
947 10 0 MSON
Emcee:  DAVID BROWN Type:  Unmoderated
This has been a strong mover lately. Anyone follow this one or have any thoughts? They recently licenced some type of new surgical technology to Us Surgical.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
947Bioventus (NASDAQ: BVS) stockholders approved the company's previously annoSavant-10/26/2021
946MSON, CRY deal Neopatch seekingalpha.comSavant-12/19/2019
945Misonix to Report Fiscal 2019 First Quarter Financial Results and Host ConfSavant-10/19/2018
944Misonix Demonstrates neXus, the First Fully Integrated, Smart Technology UlSavant-10/12/2018
943MSON results good, but PPS dropped from 21+ to 13+, rebounding for now/FinancialSavant-9/6/2018
942Misonix to Report Fiscal 2018 Fourth Quarter Financial Results and Host ConSavant-8/27/2018
941Misonix Reports Fiscal Year 2017 Financial Results FARMINGDALE, N.Y., Aug. 22, Savant-8/23/2017
940So, MSON from 3.83 low to 12.00 high, over last yearSavant-4/28/2017
939Misonix Files Form 10-K Announcing Fiscal 2016 Financial Results 4:15 PM ET 2/9Savant-2/9/2017
938DEC 19...Misonix, Inc. (NASDAQ: MSON), a leading provider of ultrasonic surgicalSavant-12/19/2016
937CC today, plus... FARMINGDALE, N.Y., Aug. 20, 2015 /PRNewswire/ -- Misonix, IncSavant-8/20/2015
936 Additional Data Confirms Reduction In Blood Loss With Misonix SonicOSavant-4/30/2015
935 Misonix Announces Exclusive Supply Agreement With MedAssets For BoneSavant-4/30/2015
934 Misonix Announces Presentation At Leading Wound Conference ConfirmsSavant13/18/2015
933Misonix, Inc. Announces Second Quarter Fiscal Year 2015 Financial Results Savant12/4/2015
932MISONIX, Inc. (MISONIX) has released its latest clinical publication, Savant-12/17/2014
931Misonix, Inc. Announces Fourth Quarter and Fiscal Year End 2014 Financial ResultSavant19/11/2014
930 Misonix, Inc. Enhances its Digital Presence with the Unveiling of itSavant-7/24/2014
929 Misonix BoneScalpel(TM) Reported to Save Blood Loss in Spinal FusionSavant-7/16/2014
928 Ultrasonic BoneScalpel(TM) Making Spine Surgery Safe and EfficientFASavant-6/4/2014
927 Poster Featuring Misonix BoneScalpel(TM) Wins Best in Show Award at Savant-1/31/2014
926 Misonix Exhibits at the Annual New York Podiatric Clinical ConferencSavant-1/31/2014
925Misonix Exhibits at the Annual Medstar Georgetown Diabetic Limb Salvage ConferenSavant-10/22/2013
924 Misonix, Inc. Terminates Agreement with PuriCoreFARMINGDALE, N.Y., Oct. 11, 201Savant-10/16/2013
923Misonix, Inc. Receives Clearance for the Sale of the BoneScalpel(TM) in the PeopSavant-7/16/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):